Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 11/20 | 0.76 |
| ▸ | ACE | P12821 | 9/20 | 0.76 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | CPA1 | P15085 | 1/20 | 0.41 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.41 |
| ▸ | TACR1 | P25103 | 2/20 | 0.40 |
| ▸ | MMP9 | P14780 | 2/20 | 0.39 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
| ▸ | MMP14 | P50281 | 1/20 | 0.38 |
| ▸ | PTGES | O14684 | 1/20 | 0.38 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8027175 | 1.00 | MME (0.76) | MMEACEL3MBTL1CPA1ACE2 | |
| SCHEMBL27443651 | 0.95 | MME (0.68) | MMEACEL3MBTL1CPA1ACE2 | |
| SCHEMBL8032591 | 0.95 | MME (0.75) | MMEACEL3MBTL1CPA1ACE2 | |
| SCHEMBL27440148 | 0.92 | MME (0.63) | MMEACEL3MBTL1TACR1PTGES | |
| SCHEMBL8017267 | 0.87 | MME (1.00) | MMEACECPA1ACE2MMP9 | |
| SCHEMBL8027260 | 0.87 | MME (0.59) | MMEACE | |
| SCHEMBL8522752 | 0.87 | MME (0.59) | MMEACE | |
| SCHEMBL8451438 | 0.86 | MME (0.83) | MMEACECPA1ACE2TACR1 | |
| SCHEMBL8027294 | 0.86 | MME (0.83) | MMEACECPA1ACE2TACR1 | |
| SCHEMBL8028033 | 0.86 | MME (0.64) | MMEACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5891912-A | ENDOPEPTIDASE 24.11 INHIBITORS | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1999-04-06 | — | — | US | disclosed |